"Designing Growth Strategies is in our DNA"

U.S. Esoteric Testing Market Size, Share & COVID-19 Impact Analysis, By Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, Flow Cytometry, Polymerase Chain Reaction, and Others), By Test Type (Infectious Disease Testing, Endocrinology Testing, Oncology Testing, Toxicology Testing, and Others), By End-user (Hospital-based Labs, and Independent and Referral Labs), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI109235

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 11.0% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Technology

  • Enzyme-linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Mass Spectrometry
  • Flow Cytometry
  • Polymerase Chain Reaction
  • Others

By Test Type

  • Infectious Disease Testing
  • Endocrinology Testing
  • Oncology Testing
  • Toxicology Testing
  • Others

By End-user

  • Hospital-based Labs
  • Independent and Referral Labs
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann